Newsletter | July 20, 2020

07.20.20 -- Considerations For End-To-End Temperature Measurement In The Clinical Supply Chain

Virtual Summit
Featured Articles
The Challenge Of Keeping Cool

From manufacturing through delivery to the patient, pharmaceutical drugs must be maintained within strict temperature guidelines to protect the efficacy of the product. This level of protection is not exclusive to refrigerated and frozen product. Even ambient product (generally 15°C to 25°C) needs protection in climates where it can be at risk of becoming too warm or too cold.

Importer Of Record Frequently Asked Questions
Customs chaos occurs when avoidable errors result in customs delays, preventing on-time delivery of clinical materials to investigator sites. The need to prevent such delays underscores the importance for sponsors of selecting the right importer of record (IOR). This e-book examines the IOR and customs clearance processes.
Early Licensure Of A Breakthrough Cancer Drug Gives Hope To Patients

No clinical supply request could be a higher priority than that of a physician urgently seeking an investigational cancer drug for a patient who has exhausted all treatment options. Read how named patient and expanded access programs helped speed the licensure of a breakthrough cancer drug.

How To Select The Best Courier Around The Globe

As a leading biotechnology company's pipeline and global presence continued to grow, management of the supply chain presented challenges. Additionally, cost pressures demanded a tighter supply chain with better control over inventory levels, and there was a need for increased temperature monitoring of clinical supplies in transit. Learn how data-driven decisions allowed them to realize cost and performance improvements across the supply chain.